地尔硫联用卡马西平致大疱性表皮坏死松解型药疹1例
出处
《海峡药学》
2010年第8期274-274,共1页
Strait Pharmaceutical Journal
二级参考文献9
-
1Bastuji-Garin S, Rzany B, Stem RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol, 1993, 129 ( 1 ): 92-96.
-
2Bastuji-Garin S, Fouchard N, Bertocehi M, et al. SCORTEN: a severity of illness score for toxic epidermal neerolysis. J Invest Dermatol, 2000, 115(2): 149-153.
-
3Imahara SD, Holmes JH, Heirnbaeh DM, et al. SCORTEN Overestimates Mortality in the Setting of a Standardized Treatment Protocol. J Burn Care Res, 2006, 27(3 ): 270-275.
-
4Cartotto R, Mayich M, Nickerson N, et al. SCORTEN Accurately Predicts Mortality Among Toxic Epidermal Neerolysis Patients Treated in a Burn Center. J Bum Care Res, 2008, 29 (1): 141-146.
-
5Guegan S, Bastuji-Garin S, Poszepczynska-Guigne E, et al. Performance of the SCORTEN During the First Five Days of Hospitalization to Predict the Prognosis of Epidermal Necrolysis. J Invest Dermatol, 2006, 126(2): 272-276.
-
6Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States. Arch Dermatol, 2004, 140(7): 890- 892.
-
7Liddell FD. Simple exact analysis of the standardized mortality ratio. J Epidemiol Community Health, 1984, 38( 1 ): 85-88.
-
8Khalili B, Bahna SL. Pathogancsis and recent therapoutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol, 2006, 97(3 ): 272-280.
-
9Gerdts B, Vloemans AF, Kreis RW. Toxic epidermal neerolysis; 15 years' experience in a Dutch bums centre. J Ettr Aead Dermatol Venereol, 2007, 21(6): 781-788.
共引文献35
-
1徐晓彤,魏淑相.大疱性表皮松解坏死型药疹的治疗体会[J].内蒙古中医药,2023,42(2):31-34. 被引量：1
-
2郭凯,朱斌,常莹莹.XELOX化疗方案致Stevens-Johnson综合征1例[J].中国临床药学杂志,2022,31(9):701-704. 被引量：2
-
3王维,陈丹.大剂量静用人免疫球蛋白冲击疗法联合糖皮质激素治疗大疱性类天疱疮的临床观察及护理[J].中国现代药物应用,2010,4(5):192-193. 被引量：8
-
4周小勇,孔庆云,周飞红,万媛,段逸群.重症多形性红斑/中毒性表皮坏死松解症29例临床分析[J].临床皮肤科杂志,2010,39(12):758-759. 被引量：1
-
5刘建军,吕世超,杨鹤鸣,李斌,刘军连,夏天保.皮下埋置卡马西平致中毒性表皮坏死松解症型药疹一例[J].实用皮肤病学杂志,2012,5(6):372-373.
-
6汝玲.临床药师参与个体化给药方案设计的临床实践与案例分析[J].中国医院用药评价与分析,2013,13(3):273-276. 被引量：3
-
7杨永生,徐金华.大疱表皮松解型药疹的研究进展[J].世界临床药物,2013,34(6):325-327. 被引量：15
-
8潘月飞,付萌,刘玉峰.中毒性表皮坏死松解症的研究进展[J].国际皮肤性病学杂志,2013,39(4):252-254. 被引量：3
-
9陈霞,谭兵.1例卡马西平致中毒性表皮坏死松解症病例报道及文献分析[J].中国药房,2014,25(4):360-362. 被引量：3
-
10程云忠,龚春龙,鲍同柱,舒迅,周纳新,万峰.血栓通与哌拉西林致中毒性表皮坏死松解症一例并文献复习[J].实用药物与临床,2014,17(10):1329-1331. 被引量：3
-
1胥雅娜,王方灿.卡马西平致大疱性表皮坏死松解型药疹2例报告[J].儿科药学,2001,7(1):43-43. 被引量：1
-
2张云玲,左国营,刘姣,夏伟,李淑娟.哌拉西林/他唑巴坦联用阿昔洛韦致大疱性表皮坏死松解型药疹[J].药物流行病学杂志,2013,22(12):686-686. 被引量：1
-
3药物反应[J].中国医学文摘（皮肤科学）,2008,25(2):100-101.
-
4李邦奇.类风关治疗问题探讨[J].自然杂志,1993,16(11):78-78.
-
5杨淼,张柯.血液灌流联合激素治疗慢性肾衰竭合并大疱性表皮坏死松解型药疹1例[J].中国医学前沿杂志（电子版）,2013,5(5):68-69.
-
6于雪松.1例青霉素致大疱性表皮坏死松解型药疹的护理[J].护理研究,2002,16(6):371-371. 被引量：2
-
7杨秋亚,赵继红.卡马西平致大疱性表皮坏死松解型药疹2例[J].中国药业,2005,14(4):55-55. 被引量：9
-
8高波,王上上,徐峰,李中东,钟明康.别嘌醇所致药疹的临床特征及其肾功能与预后的关系[J].药学服务与研究,2014,14(1):42-44. 被引量：8
-
9药物反应[J].中国医学文摘（皮肤科学）,2008,25(1):29-31.
-
10张江霞.大疱性表皮坏死松解型药疹1例分析[J].中国医药指南,2016,14(27):201-201. 被引量：2
